Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer
AUAUniversity31 Mars 2017

Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer

The goal of this knowledge-based activity is to improve clinicians' understanding of current immunotherapeutic agents for the treatment of bladder cancer and to increase their ability to improve patient outcomes and the management of adverse events. Educational grants provided by the following corportations: AstraZeneca, Bristol-Myers Squibb, Genentech, Merck

Avsnitt(425)

Populärt inom Utbildning

historiepodden-se
rss-bara-en-till-om-missbruk-medberoende-2
det-skaver
alska-oss
harrisons-dramatiska-historia
sektledare
nu-blir-det-historia
rss-viktmedicinpodden
johannes-hansen-podcast
roda-vita-rosen
allt-du-velat-veta
i-vantan-pa-katastrofen
rss-sjalsligt-avkladd
rss-max-tant-med-max-villman
rss-basta-livet
rss-om-vi-ska-vara-arliga
rikatillsammans-om-privatekonomi-rikedom-i-livet
rss-relationsrevolutionen
not-fanny-anymore
sa-in-i-sjalen